BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2018

Mar 20, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2018-03-15

Reporting Person: FUCHS HENRY J (President, Worldwide R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-15	Common Stock	F	4861	$83.57	Disposed	146448	Direct
2018-03-15	Common Stock	A	16040	—	Acquired	162488	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-15	Stock Option (Right to buy Common Stock)	$83.57	A	51300	Acquired	2028-03-14	Common Stock (51300)	Direct

Footnotes

F1: Restricted stock units granted on March 15, 2018. Price not applicable.

F2: Option grant vests 12/48th on March 15, 2019 and 1/48th on the 15th day of each month thereafter.